Infinium Pharmachem Ltd
INFINIUMInfinium Pharmachem Ltd
INFINIUM
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| — | 7.04 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 30.03 | 3.41 | 1.36% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
The Company is involved in the development, manufacture, and export of a spectrum of the Iodine Derivatives that are used in pharmaceutical, chemical, biotech and allied industries across the globe.
Peers
Compare with peersSolar Industries India Ltd
Linde India Ltd
Deepak Nitrite Ltd
Himadri Speciality Chemical Ltd
Sumitomo Chemical India Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 39.41 | 71.15 | 100.05 | 115.57 | 137.18 | — | ||||||
Raw Materials | 31.18 | 57.91 | 78.36 | 80.17 | 108.05 | — | ||||||
| Power & Fuel Cost | 0.32 | 0.50 | 0.77 | 0.63 | 1.12 | |||||||
| Employee Cost | 2.09 | 2.75 | 3.54 | 5.37 | 5.91 | |||||||
| Selling & Administrative Expenses | 2.89 | 6.03 | 7.31 | 10.19 | 5.07 | |||||||
| Operating & Other expenses | -0.12 | -1.62 | -0.89 | 1.82 | -3.04 | |||||||
EBITDA | 3.05 | 5.58 | 10.96 | 17.39 | 20.07 | — | ||||||
| Depreciation/Amortization | 0.58 | 0.65 | 0.63 | 1.34 | 2.67 | — | ||||||
| PBIT | 2.47 | 4.93 | 10.33 | 16.05 | 17.40 | — | ||||||
| Interest & Other Items | 1.24 | 1.16 | 1.70 | 3.10 | 2.19 | — | ||||||
| PBT | 1.23 | 3.77 | 8.63 | 12.95 | 15.21 | — | ||||||
| Taxes & Other Items | 0.30 | 1.05 | 2.53 | 3.47 | 3.90 | — | ||||||
| Net Income | 0.93 | 2.72 | 6.10 | 9.48 | 11.31 | — | ||||||
| EPS | 0.23 | 0.67 | 1.50 | 2.33 | 4.14 | — | ||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | ||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Company Updates
Peers & Comparison
MaterialsCommodity Chemicals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Infinium Pharmachem Ltd | 37.47 | 7.04 | — |
| Solar Industries India Ltd | 111.74 | 27.26 | 0.08% |
| Linde India Ltd | 129.00 | 16.15 | 0.18% |
| Deepak Nitrite Ltd | 44.29 | 7.45 | 0.28% |
Price Comparison
Compare INFINIUM with any stock or ETFShareholdings
Promoter Holdings Trend
Institutional Holdings Trend
Increased Total Retail Holding
In last 3 months, retail holding in the company has increased by 8.16%
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Sep 2023
Mar 2024
Sep 2024
Nov 2024
Shareholding History
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
INFINIUM has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Hmm, looks like data is unavailable here. Please come back after some timeInfinium Pharmachem will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live
Infinium Pharmachem announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 23 October 2024 .Powered by Capital Market - Live
Infinium Pharmachem will hold a meeting of the Board of Directors of the Company on 1 October 2024.Powered by Capital Market - Live
Infinium Pharmachem will hold a meeting of the Board of Directors of the Company on 2 September 2024.Powered by Capital Market - Live
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant